Kolzhetsov Nikolay, Markelova Natalia, Frolova Maria, Alikina Olga, Glazunova Olga, Safonova Lubov, Kalashnikova Irina, Yudin Vladimir, Makarov Valentin, Keskinov Anton, Yudin Sergey, Troshina Daria, Rechkina Viktoria, Shcherbakova Viktoria, Shavkunov Konstantin, Ozoline Olga
Laboratory of Functional Genomics of Prokaryotes, Institute of Cell Biophysics of the Russian Academy of Sciences, Federal Research Center "Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences", 142290 Pushchino, Russia.
Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, 119121 Moscow, Russia.
Int J Mol Sci. 2024 Apr 22;25(8):4558. doi: 10.3390/ijms25084558.
Beneficial properties of lactic acid bacteria have been known long ago, but particular interest in probiotics has arisen in the last two decades due to the understanding of the important role of intestinal microflora in human life. Thus, the ability of probiotics to support healthy homeostasis of gut microbiomes has received particular attention. Here, we evaluated the effect of a probiotic consisting of and on the gut microbiome of male rats, assessed their persistence in the fecal biota, and compared probiotic-mediated changes in vitro and in vivo. As expected, microbiomes of two enterotypes were identified in the feces of 21 animals, and it turned out that even a single dose of the probiotic altered the microbial composition. Upon repeated administration, the E1 biota temporarily acquired properties of the E2 type. Being highly sensitive to the intervention of probiotic bacteria at the phylum and genus levels, the fecal microbiomes retained the identity of their enterotypes when transferred to a medium optimized for gut bacteria. For the E2 biota, even similarities between probiotic-mediated reactions in vitro and in vivo were detected. Therefore, fecal-derived microbial communities are proposed as model consortia to optimize the response of resident bacteria to various agents.
乳酸菌的有益特性早在很久以前就为人所知,但由于认识到肠道微生物群在人类生活中的重要作用,在过去二十年中人们对益生菌产生了特别的兴趣。因此,益生菌支持肠道微生物群落健康稳态的能力受到了特别关注。在此,我们评估了一种由[具体成分未给出]组成的益生菌对雄性大鼠肠道微生物群的影响,评估了它们在粪便生物群中的持久性,并比较了益生菌在体外和体内介导的变化。正如预期的那样,在21只动物的粪便中鉴定出了两种肠型的微生物群,结果表明即使单剂量的益生菌也会改变微生物组成。反复给药后,E1生物群暂时获得了E2型的特性。粪便微生物群在门和属水平上对益生菌的干预高度敏感,当转移到针对肠道细菌优化的培养基中时,它们保留了其肠型的特征。对于E2生物群,甚至在体外和体内检测到了益生菌介导反应之间的相似性。因此,建议将粪便来源的微生物群落作为模型联合体,以优化常驻细菌对各种因子的反应。